Skip to main content
SpringerLink
Log in

Diagnosis and Treatment of Non-ST-Segment Elevation Myocardial Infarction

  • Chapter
Book cover Acute Coronary Syndrome

  • 1528 Accesses

Acute coronary syndrome (ACS) is a spectrum of clinical events ranging from unstable angina (UA) to acute myocardial infarction (AMI). AMI includes both non-ST-segment elevation myocardial infarction (NSTEMI) and ST-segment elevation myocardial infarction (STEMI). UA and NSTEMI have similar patho-physiologic and clinical presentations. Often they are diffi cult to distinguish on initial appearance and are frequently grouped together as one clinical syndrome. However, NSTEMI portends an increased risk due to an elevation in cardiac biomarkers refl ecting myocardial necrosis. NSTEMI is a highly prevalent and life-threatening manifestation of ACS accounting for more than 1.2 million patient hospitalizations in the United States alone [1] and is a major cause of morbidity and mortality in the Western world.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Log in via an institution
Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 84.99
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD 109.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. Patel MR, Chen AY, Peterson ED, et al. Prevalence, predictors, and outcomes of patients with non-ST-segment elevation myocardial infarction and insignificant coronary artery disease: results from the Can Rapid risk stratification of Unstable angina patients Suppress ADverse outcomes with Early implementation of the ACC/ AHA Guidelines (CRUSADE) initiative. Am Heart J 2006;152:641–7.

    Article  PubMed  Google Scholar 

  2. Davies MJ. The pathophysiology of acute coronary syndromes. Heart 2000;83:361–366.

    Article  PubMed  CAS  Google Scholar 

  3. Braunwald E, Antman EM, Beasley JW, et al. ACC/AHA guidelines for the management of patients with unstable angina and non ST segment elevation myocardial infarction. A report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Committee on the Management of Patients with Unstable Angina). J Am Coll Cardiol 2000;36:970–1062.

    Article  PubMed  CAS  Google Scholar 

  4. Braunwald E, Antman EM, Beasley JW, et al. ACC/AHA 2002 guideline update for the management of patients with unstable angina and non-ST segment elevation myocardial infarction: a report of the American College of Cardiology/ American Heart Association Task Force on Practice Guidelines (Committee on the Management of Patients with Unstable Angina). Circulation 2002;106:1893.

    Article  PubMed  Google Scholar 

  5. Rouan GW, Lee TH, Cook EF, et al. Clinical characteristics and outcome of acute myocardial infarction in patients with initially normal or nonspecific electrocardiograms (a report from the Multicenter Chest Pain Study). Am J Cardiol 1989;64:1087–1092.

    Article  PubMed  CAS  Google Scholar 

  6. Cannon CP, McCabe CH, Stone PH, et al. The electrocardiogram predicts one-year outcome of patients with unstable angina and non-Q wave myocardial infarction: results of the TIMI III registry ECG ancillary study. Thrombolysis in Myocardial Ischemia. J Am Coll Cardiol 1997;30:133–140.

    Article  PubMed  CAS  Google Scholar 

  7. Welch RD, Zalenski RJ, Frederick PD, et al. Prognostic value of a normal or non-specific initial electrocardiogram in acute myocardial infarction. JAMA 2001;286:1977–1984.

    Article  PubMed  CAS  Google Scholar 

  8. Antman EM, Cohen M, Bernink PJ, et al. The TIMI risk score for unstable angina/ non ST-segment elevation MI; a method for prognostication and therapeutic decision making. JAMA 2000;284:835–842.

    Article  PubMed  CAS  Google Scholar 

  9. Katz DA, Griffith JL, Beshansky JR, et al. The use of empiric clinical data in the evaluation of practice guidelines for unstable angina. JAMA 1996;276:1568– 1574.

    Article  PubMed  CAS  Google Scholar 

  10. Pettijohn JL, Doyle T, Spiekerman AL, et al. Usefulness of positive troponin-T and negative creatine kinase levels in identifying high-risk patients with unstable angina pectoris. Am J Cardiol 1997;80:510–511.

    Article  PubMed  CAS  Google Scholar 

  11. Antman EM, Tanasijevic MJ, Thompson B, et al. Cardiac-specific troponin-I levels to predict the risk of mortality in patients with acute coronary syndromes. N Engl J Med 1996;335:1342–1349.

    Article  PubMed  CAS  Google Scholar 

  12. Lindahl B, Venge P, Wallentin L. Relation between troponin T and the risk of subsequent cardiac events in unstable coronary artery disease. The FRISC study group. Circulation 1996;93:1651–1657.

    CAS  Google Scholar 

  13. Newby LK, Ohman EM, Christenson RH, et al. Benefit of glycoprotein IIb/IIIa inhibition in patients with acute coronary syndromes and troponin t-positive status: the paragon-B troponin T substudy. Circulation 2001;103:2891–2896.

    PubMed  CAS  Google Scholar 

  14. Hamm CW, Heeschen C, Goldmann B, et al. Benefit of abciximab in patients with refractory unstable angina in relation to serum troponin T levels. c7E3 Fab Anti-platelet Therapy in Unstable Refractory Angina (CAPTURE) Study Investigators. N Engl J Med 1999;340:1623–1629.

    Article  PubMed  CAS  Google Scholar 

  15. Heeschen C, Hamm CW, Goldmann B, et al. Troponin concentrations for stratification of patients with acute coronary syndromes in relation to therapeutic efficacy of tirofiban. PRISM Study Investigators. Platelet Receptor Inhibition in Ischemic Syndrome Management. Lancet 1999;354:1757–1762.

    CAS  Google Scholar 

  16. ISIS-4: a randomized factorial trial assessing early oral captopril, oral mononitrate, and intravenous magnesium sulfate in 58,050 patients with suspected acute myo-cardial infarction. ISIS-4 (Fourth International Study of Infarct Survival) Collaborative Group. Lancet 1995;345:669–685.

    Article  Google Scholar 

  17. GISSI-3: Effects of lisinopril and transdermal glyceryl trinitrate singly and together on 6-week mortality and ventricular function after acute myocardial infarction. Gruppo Italiano per lo Studio della Sopravvivenza nell'infarto Miocardico. Lancet 1994;343:1115–1122.

    Google Scholar 

  18. Randomized trial of intravenous atenolol among 16 027 cases of suspected acute myocardial infarction: ISIS-1. First International Study of Infarct Survival Collaborative Group. Lancet 1986;2:57–66.

    Google Scholar 

  19. Roberts R, Rogers WJ, Mueller HS, et al. Immediate versus deferred beta-blockade following thrombolytic therapy in patients with acute myocardial infarction. Results of the Thrombolysis in Myocardial Infarction (TIMI) II-B. Circulation 1991;83(2): 422–437.

    PubMed  CAS  Google Scholar 

  20. Gibson RS, Boden WE. Calcium channel antagonists: friend or foe in postinfarction patients? Am J Hypertens 1996;9:172s–176s.

    Article  PubMed  CAS  Google Scholar 

  21. Theroux P, Taeymans Y, Morissette D, et al. A randomized study comparing pro-pranolol and diltiazem in the treatment of unstable angina. J. Am Coll Cardiol 1985; 5:717–722.

    Article  PubMed  CAS  Google Scholar 

  22. Meine TJ, Roe MT, Chen AY, et al. Association of intravenous morphine use and outcomes in acute coronary syndromes: results from the CRUSADE Quality Improvement Initiative. Am Heart J 2005;149:1043–1049.

    Article  PubMed  CAS  Google Scholar 

  23. Cairns JA, Gent M, Singer J, et al. Aspirin, sulfinpyrazone, or both in unstable angina. Results of a Canadian multicenter trial. N Engl J Med 1985;313:1369– 1375.

    CAS  Google Scholar 

  24. Yusuf S, Wittes J, Friedman L. Overview of results of randomized clinical trials in heart disease. II. Unstable angina, heart failure, primary prevention with aspirin and risk factor modification. JAMA 1988;260:2259–2263.

    Article  PubMed  CAS  Google Scholar 

  25. The Clopidogrel in Unstable Angina to Prevent Recurrent Events Trial Investigators. Effect of Clopidogrel in addition to Aspirin in patients with acute coronary syndromes without ST segment elevation. N Engl J Med 2001;345:494–502.

    Article  Google Scholar 

  26. Mehta SR, Yusuf S, Peters RJ, et al. Effects of pretreatment with clopidogrel and aspirin followed by long-term therapy in patients undergoing percutaneous coronary intervention: the PCI-CURE study. Lancet 2001;358:527–533.

    Article  PubMed  CAS  Google Scholar 

  27. Steinhubl SR, Berger PB, Mann JT III, and the CREDO investigators. Early and sustained dual oral antiplatelet therapy following percutaneous coronary intervention: a randomized controlled trial. JAMA 2002;288:2411–2420.

    Article  PubMed  CAS  Google Scholar 

  28. The RESTORE Investigators. Effects of platelet glycoprotein IIb/IIIa blockade with tirofiban on adverse cardiac events in patients with unstable angina or acute myo-cardial infarction undergoing coronary angioplasty. Circulation 1997;96:1445–1453.

    Google Scholar 

  29. Inhibition of platelet glycoprotein IIb/IIIa with eptifibatide in patients with acute coronary syndromes. The PURSUIT Trial Investigators. Platelet glycoprotein IIb/IIIa in unstable angina: receptor suppression using int therapy. N Engl J Med 1998;339:436–443.

    Article  Google Scholar 

  30. Simoons ML; GUSTO IV-ACS Investigators. Effect of glycoprotein IIb/IIIa receptor blocker abciximab on outcome in patients with acute coronary syndromes without early coronary revascularization: the GUSTO IV-ACS randomized trial. Lancet. 2001;357:1915–1924.

    Article  PubMed  CAS  Google Scholar 

  31. Platelet Receptor Inhibition in Ischemic Syndrome Management (PRISM) Study Investigators. A comparison of aspirin plus tirofiban with aspirin plus heparin for unstable angina. N Engl J Med 1998;338:1498–5056.

    Article  Google Scholar 

  32. Huynh T, Theroux P, Snapinn S, et al. Effect of platelet glycoprotein IIb/IIIa receptor blockade with tirofiban on adverse cardiac events in women with unstable angina/ non-ST-elevation myocardial infarction (PRISM-PLUS Study). Am Heart J 2003;146:668–673.

    Article  PubMed  CAS  Google Scholar 

  33. Risk of myocardial infarction and death during treatment with low dose aspirin and intravenous heparin in men with unstable coronary artery disease. The RISC Group. Lancet 1990;336:827–830.

    Article  Google Scholar 

  34. Theroux P, Ouimet H, McCans J, et al. Aspirin, heparin, or both to treat acute unstable angina. N Engl J Med 1988;319:1105–1111.

    PubMed  CAS  Google Scholar 

  35. Antman EM, Cohen M, Radley D, et al. Assessment of the treatment effect of enoxa-parin for unstable angina/non-Q wave myocardial infarction. TIMI IIb-ESSENCE meta-analysis. Circulation 1999;100:1602–1608.

    PubMed  CAS  Google Scholar 

  36. Bijsterveld NR, Peters RJ, Murphy SA, et al. Recurrent cardiac ischemic events early after discontinuation of short-term heparin treatment in acute coronary syndromes: results from the Thrombolysis in Myocardial Infarction (TIMI) 11B and Efficacy and Safety of Subcutaneous Enoxaparin in Non-Q-Wave Coronary Events (ESSENCE) studies. J Am Coll Cardiol 2003;42:2083–2089.

    Article  PubMed  CAS  Google Scholar 

  37. Ferguson JJ, Califf RM, Antman EM, and the SYNERGY Trial Investigators. Enoxa-parin vs. unfractionated heparin in high-risk patients with non-ST-segment elevation acute coronary syndromes managed with an intended early invasive strategy: primary results of the SYNERGY randomized trial. JAMA 2004;292:45–54.

    Article  PubMed  CAS  Google Scholar 

  38. Tokmakova MP, Skali H, Kenchaiah S, et al. Chronic kidney disease, cardiovascular risk, and response to angiotensin-converting enzyme inhibition after myocardial infarction: the Survival And Ventricular Enlargement (SAVE) study. Circulation 2004;110:3667–3673.

    Article  PubMed  CAS  Google Scholar 

  39. Borghi C, Bacchelli S, Esposti DD, et al. Effects of the administration of an angio-tensin-converting enzyme inhibitor during the acute phase of myocardial infarction in patients with arterial hypertension. SMILE Study Investigators. Survival of Myo-cardial Infarction Long-term Evaluation. Am J Hypertens 1999;12:665–672.

    Article  PubMed  CAS  Google Scholar 

  40. Treasure CB, Klein JL, Weintraub WS, et al. Beneficial effects of cholesterol-lowering therapy on the coronary endothelium in patients with coronary artery disease. New Engl J Med 1995;332:481–487.

    Article  PubMed  CAS  Google Scholar 

  41. Cannon CP, Braunwald E, McCabe CH, and the Pravastatin or Atorvastatin Evaluation and Infection Therapy—Thrombolysis in Myocardial Infarction 22 Investigators. Intensive versus Moderate Lipid Lowering with Statins after Acute Coronary Syndromes. N Engl J Med 2004:350:1495–1504.

    Article  PubMed  CAS  Google Scholar 

  42. Nissen SE, Murat TE, Schoenhagen P, et al. Effect of intensive compared with moderate lipid-lowering therapy on progression of coronary atherosclerosis: a randomized controlled trial. JAMA 2004;291:1071–1080.

    Article  PubMed  CAS  Google Scholar 

  43. Hulten E, Jackson JL, Douglas K, et al. The effect of early, intensive statin therapy on acute coronary syndrome: a meta-analysis of randomized controlled trials. Arch Intern Med 2006;166:1814–1821.

    Article  PubMed  CAS  Google Scholar 

  44. Fragmin and Fast Revascularisation during Instability in Coronary Artery Disease (FRISC II) Investigators. Invasive compared with non-invasive treatment in unstable coronary artery disease: FRISC II prospective randomized multicenter study. Lancet 1999;354:708–715.

    Article  Google Scholar 

  45. Cannon CP, Weintraub WS, Demopoulos LA, and TACTICS (Treat Angina with Aggrastat and Determine Cost of Therapy with an Invasive or Conservative Strat-egy)—Thrombolysis in Myocardial Infarction 18 Investigators. Comparison of early invasive and conservative strategies in patients with unstable coronary syndromes treated with the glycoprotein IIb/IIIa inhibitor tirofiban. N Engl J Med 2001;344:1879–1887.

    Article  PubMed  CAS  Google Scholar 

  46. Fox KA, Poole-Wilson P, Clayton TC, et al. 5-year outcome of an international strategy in non-ST elevation acute coronary syndrome: the British Heart Foundation RITA 3 randomized trial. Lancet 2005;366:914–920.

    Article  PubMed  CAS  Google Scholar 

  47. de Winter RJ, Windhausen F, Cornel JH, and the Invasive versus Conservative Treatment in Unstable Coronary Syndromes (ICTUS) Investigators. Early invasive versus selectively invasive management for acute coronary syndromes. N Engl J Med 2005; 353:1095–1104.

    Article  PubMed  Google Scholar 

  48. Bavry AA, Kumbhani DJ, Rassi AN, et al. Benefit of early invasive therapy in acute coronary syndromes: a meta-analysis of contemporary randomized clinical trials. J Am Coll Cardiol 2006;48:1319–1325.

    Article  PubMed  Google Scholar 

  49. Edlavitch SA, Crow R, Burke GL, et al. Secular trends in Q wave and non-Q wave acute myocardial infarction. The Minnesota Heart Survey. Circulation 1991;83:492–503.

    CAS  Google Scholar 

  50. Peterson ED, Pollack CV Jr, Roe MT, et al. Early use of glycoprotein IIb/IIIa inhibitors in non–ST-elevation acute myocardial infarction: observations from the National Registry of Myocardial Infarction 4. J Am Coll Cardiol 2003;42;45–53.

    Article  PubMed  CAS  Google Scholar 

  51. Ryan JW, Peterson ED, Chen AY, et al. Optimal timing of intervention in non–ST-segment elevation acute coronary syndromes: insights from the CRUSADE (Can Rapid risk stratification of Unstable angina patients Suppress ADverse outcomes with Early implementation of the ACC/AHA guidelines) Registry. Circulation 2005;112;3049–3057.

    Article  PubMed  Google Scholar 

  52. Ticoci, P, Peterson ED, Roe MT, et al. Patterns of guideline adherence and care delivery for patients with unstable angina and non-ST segment elevation myocardial infarction (from the CRUSADE Quality Improvement Initivative). Am J Cardiol 2006;98:S30–S35.

    Article  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Division of Cardiology Department of Medicine, St. Luke's-Roosevelt Hospital Center Columbia University College of Physicians and Surgeons, New York, NY, USA

    Jacqueline E. Tamis-Holland BA & Sandeep Joshi MD

  2. Department of Cardiology, St. Luke's-Roosevelt Hospital Center Columbia University College of Physicians and Surgeons, New York, NY, USA

    Angela Palazzo MD, FACC & Sripal Bangalore MD, MHA

Authors
  1. Jacqueline E. Tamis-Holland BA
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Sandeep Joshi MD
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Angela Palazzo MD, FACC
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. Sripal Bangalore MD, MHA
    View author publications

    You can also search for this author in PubMed Google Scholar

Editor information

Editors and Affiliations

  1. Cardiac Catheterization Laboratory and Interventional Cardiology, Department of Medicine, St. Luke's-Roosevelt Hospital Center, Columbia University College of Physicians and Surgeons, New York, NY, USA

    Mun K. Hong MD

  2. Cardiac Care Unit, St. Luke's-Roosevelt Hospital Center, Columbia University College of Physicians and Surgeons, New York, NY, USA

    Eyal Herzog MD, FACC

Rights and permissions

Reprints and permissions

Copyright information

© 2008 Springer-Verlag London Limited

About this chapter

Cite this chapter

Tamis-Holland, J.E., Joshi, S., Palazzo, A., Bangalore, S. (2008). Diagnosis and Treatment of Non-ST-Segment Elevation Myocardial Infarction. In: Hong, M.K., Herzog, E. (eds) Acute Coronary Syndrome. Springer, London. https://doi.org/10.1007/978-1-84628-869-2_7

Download citation

  • DOI: https://doi.org/10.1007/978-1-84628-869-2_7

  • Publisher Name: Springer, London

  • Print ISBN: 978-1-84628-868-5

  • Online ISBN: 978-1-84628-869-2

  • eBook Packages: MedicineMedicine (R0)

Publish with us

Policies and ethics

Search

Navigation